DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine
NCT06347809 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2025-12-15
Summary
This study explores the potential use of DNA markers in the detection of prostate cancer and patient perceptions of this screening approach and other current or future prostate cancer screening and diagnostic tests.
Conditions
- Prostate Adenocarcinoma
- Prostate Carcinoma
Interventions
- OTHER
-
Non-Interventional Study
Non-Interventional Study
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
John B. Kisiel, M.D. · Mayo Clinic in Rochester
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-01-23
- Primary Completion
- 2025-07-31
- Completion
- 2025-07-31
Countries
- United States
Study Locations
More Related Trials
-
Markers for Early Detection of Prostate Cancer
NCT00340717 ·Status: COMPLETED
-
Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer
NCT04067713 ·Status: ACTIVE_NOT_RECRUITING
-
Changes in DNA After Radiation Therapy in Patients With Prostate Cancer
NCT00899912 ·Status: COMPLETED
-
Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy
NCT00373035 ·Status: COMPLETED
-
Non-Invasive Biomarkers in Prostate Cancer Disease Management
NCT06144619 ·Status: SUSPENDED
-
Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate Cancer
NCT03677414 ·Status: UNKNOWN
-
Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data
NCT00578409 ·Status: COMPLETED
-
Decipher Lethal Prostate Cancer Biology - Urine Metabolomics
NCT03237702 ·Status: RECRUITING ·Phase: NA
-
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
NCT05477823 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI
NCT03404648 ·Status: COMPLETED ·Phase: PHASE3
-
GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies
NCT07258056 ·Status: RECRUITING ·Phase: NA
-
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
NCT02594202 ·Status: RECRUITING
-
Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer
NCT06657131 ·Status: RECRUITING
-
Understanding of Genetics by Men at Risk for Prostate Cancer
NCT04550845 ·Status: RECRUITING ·Phase: NA
-
Circulating Tumor DNA in High Risk Localized Prostate Cancer
NCT07222436 ·Status: RECRUITING
-
MRI-Guided Cryoablation for Focal Native Prostate Cancer
NCT04797039 ·Status: RECRUITING
-
Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision
NCT06281769 ·Status: COMPLETED ·Phase: NA
-
A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3
NCT06507462 ·Status: COMPLETED
-
Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
NCT06262139 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer
NCT06482658 ·Status: COMPLETED ·Phase: NA
-
MR-Guided Cryoablation of Prostate Bed Recurrences
NCT01727284 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer
NCT03451812 ·Status: UNKNOWN
-
Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.
NCT05415787 ·Status: COMPLETED
-
Micro-RNA Expression Profiles in High Risk Prostate Cancer
NCT01220427 ·Status: TERMINATED
-
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03789253 ·Status: RECRUITING